Title

Efficacy and Safety of Guselkumab, an Anti-IL23 Monoclonal Antibody, in Patients With Active Psoriatic Arthritis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study

Document Type

Abstract

Publication Date

June 2017

Department

Dermatology

Share

COinS